An open label trial of telbivudine (LdT) in adults with chronic hepatitis B previously treated in Idenix-sponsored telbivudine studies. [Studio in aperto su Telbivudina (LdT)in soggetti adulti affetti da epatite B cronica trattati in precedenza nel corso di studi sponsorizzati da Idenix]

Trial Profile

An open label trial of telbivudine (LdT) in adults with chronic hepatitis B previously treated in Idenix-sponsored telbivudine studies. [Studio in aperto su Telbivudina (LdT)in soggetti adulti affetti da epatite B cronica trattati in precedenza nel corso di studi sponsorizzati da Idenix]

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2015

At a glance

  • Drugs Telbivudine (Primary)
  • Indications Hepatitis B
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 22 Jul 2011 Actual initiation date (Mar 2005) added as reported by ClinicalTrials.gov.
    • 22 Jul 2011 Additional trial locations identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top